IP Library Granted Patent US 8,975,023
Granted Patent B2
US 8,975,023 · App. 13/770,682 · Granted Mar 10, 2015

Method for controlling the amount of gene product, and agent for controlling the amount of gene product

Inventors: Tadayoshi Okumura (Osaka, JP); Mikio Nishizawa (Osaka, JP); Yasuo Kamiyama (Osaka, JP); Koji Wakame (Hokkaido, JP); Takehito Miura (Hokkaido, JP)
Assignees: Amino Up Chemical Co., Ltd; Kansai Medical University
C12Q1/6811A61K38/4866C12N15/111C12N15/67C12N2310/113
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,975,023
App. No.
13/770,682
Granted
Mar 10, 2015
Kind
B2
Abstract

The invention relates to a method of intracellularly controlling amounts of gene products, which can increase an amount of gene product intracellularly, comprising a step of introducing into the cell a substance having a sequence complementary to the base sequence of mRNA corresponding to the gene product, its precursor or another substance which can have equivalent action in the cell.

Claims (5)

1. A method for identifying a protein that can be overexpressed by introducing an antisense polynucleotide into a cell that expresses the protein, said method comprising:

(a) screening RNA molecules from one or more cells to identify an antisense transcript that contains a nucleotide sequence complementary to a 3′-untranslated region (UTR) of an mRNA that encodes an early-response protein, said mRNA being present in the one or more cells;

(b) introducing, into a cell expressing said mRNA, an antisense polvnucleotide containing a nucleotide sequence complementary to the 3′-untranslated region (UTR) of said mRNA, and measuring whether the introduction of said antisense polynucleotide increases expression of the early-response protein in the cell; and

(c) determining that said mRNA encodes a protein which can be overexpressed by introducing an antisense polynucleotide containing a nucleotide sequence complementary to the 3′-untranslated region (UTR) of said mRNA into a cell expressing said early-response protein, when an increase in expression of the early-response protein in the cell is measured in step (b).

2. The method of claim 1 , wherein the identification is performed by reverse transcribing RNA from one or more cells using a primer containing a sense sequence from the 5′-or 3′-end of an mRNA, and detecting the presence of a reverse-transcription product.

Assignments (1)
CHANGE OF NAME Recorded Feb 28, 2019
From: AMINO UP CHEMICAL CO., LTD.
To: AMINO UP CO., LTD.
Reel/Frame 050095/0402 →
Priority Claims (1)
JP 2006-159729 · Jun 8, 2006 · national
Continuity (2)
Division 12303908
Related Publication 20130177909A1 · Jul 11, 2013